13
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Injecting nation: Achieving control of hepatitis C in Australia

Pages 275-284 | Published online: 12 Jul 2009

References

  • Rankin J, Holst V, McKnight J, Moait S, Rae A. Committee of inquiry into the legal provision of heroin and other possible methods of diminishing crime associated with the supply and use of heroin. Sydney 1981
  • Uchtenhagen A, Dobler-Mikola A, Gutzwiller F. Medical Prescription of narcotics. Background and intermediate results of a Swiss National Project. Eur Addict Res 1996; 2: 201–207
  • Bammer G. Report and recommendations of Stage 2, feasibility research into the controlled availability of opioids. National Centre for Epidemiology and Public Health and the Australian Institute of Criminology. The Australian National University, Canberra 1995
  • Manderson D. From Mr Sin to Mr Big. A history of Australian drug laws. Oxford University Press, Melbourne 1993
  • Premier's Drug Advisory Council. Drugs and our community. Joint Departmental Information Centre, Melbourne 1996
  • Stimson G. Drug injecting and HIV infection: new directions for social science research. Int J Addict 1992; 27: 147–163
  • Parliamentary Joint Committee on the National Crime Authority. Drugs, crime and society. Australian Government Publishing Service, Canberra 1989
  • Australian Bureau of Criminal Intelligence. Australian illicit drug report 1995–96. Canberra 1996
  • Commission on Narcotic Drugs. Economic and social consequences of drug abuse and illicit drug trafficking: an interim report. United Nations Economic and Social Council, Vienna 1995
  • Westermeyer J. The pro-heroin effects of anti-opium laws in Asia. Arch Gen Psychiat 1976; 33: 1135–1139
  • Nadelmann E. Drug prohibition in the United States: costs, consequences and alternatives. Science 1989; 245: 939–947
  • Wodak A, Owens R. Drug prohibition: a call for change. UNSW Press, Sydney 1995
  • Mann JM, Tarantola DJ, Netter TW. Aids in the world: the global AIDS policy coalition. Harvard University Press, Cambridge 1992
  • Riley KJ. Snow job? The war against international cocaine trafficking. Transaction Publishers, New Brunswick 1996
  • Department of Health, Housing and Community Services. Statistics on drug abuse in Australia 1992. Australian Government Publishing Service, Canberra 1992
  • Crofts N, Jolly D, Kaldor J, van Beek I, Wodak A. The epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epi Comm Health, in press
  • Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, B human immunodeficiency and human t-lymphotropic viruses. Am J Pub Health 1996; 86: 655–661
  • Moaven LD, Crofts N, Locarnini SA. Hepatitis C virus in Victorian injecting drug users in 1971 (letter). Med J Aust 1993; 158: 574–574
  • Wodak A, Crofts N. Once more unto the breach: controlling hepatitis C in injecting drug users. Addiction 1996; 91: 181–184
  • Wodak A, Crofts N. HIV revisited: preventing the spread of blood borne viruses among injecting drug users. Aust J Publ Health (Editorial) 1994; 18: 239–241
  • MacDonald M, Wodak A, Ali R. HIV prevalence and risk behaviour in needle exchange attenders. Med J Aust 1997; 166: 237–240
  • Gerbeding JL. Drug therapy: management of occupational exposures to blood-borne viruses. N Engl J Med 1995; 332: 444–451
  • Albertis A, Realdi G. Parentally-acquired non-A, non-B (type C) hepatitis. Oxford textbook of clinical hepatology, N McIntyre, J-P Benhamou, J Bircher, M Rizzetto, J Rodes. Oxford University Press, Oxford 1991; 605–617, In
  • Seeff LB, Buskell-Bales Z, Wright EC, et al. Long term mortality after transfusion associated non-A, non-B hepatitis. N Engl J Med 1992; 327: 1906–1911
  • Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463–1466
  • Hagan H, Des Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Publ Health 1995; 85: 1531–1537
  • Feachem RGA. Valuing the past … investing in the future. Evaluation of the National HIV/AIDS Strategy 1993–94 to 1995–96. Commonwealth Department of Human Services and Health. Australian Government Publishing Service, Canberra 1995
  • United States General Accounting Office. Confronting the drug problem: debate persists on enforcement and alternative approaches. US Government Report, Washington DC 1993
  • Griffiths P, Gossop M, Powis B, Strang J. Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. Addiction 1994; 89: 301–309
  • Griffiths P, Gossop M, Strang J. Chasing the dragon: the development of heroin smoking in the United Kingdom. Heroin addiction and drug policy. The British system, J Strang, M Gossop. Oxford University Press, Oxford 1994; 121–133, In
  • Grund J-P, Blanken P. From chasing the dragon to chinezen. The diffusion of heroin smoking in the Netherlands. Instituut voor Verslavingsonderzoek (IVO). Erasmus Universiteit, Rotterdam 1993
  • The public health impact of needle exchange programs in the United States and abroad, vol. I, P Lurie, AL Reingold, B Bowser, et al. University of California, San Francisco 1993
  • National Research Council and Institute of Medicine. Preventing HIV transmission. The role of sterile neeldes and bleach. National Academy Press, Washington DC 1995
  • Weatherburn D, Lind B. Drug law enforcement policy and its impact on the heroin market. New South Wales Bureau of Crime Statistics and Research, Sydney 1995
  • Single E. The impact of marihuana decriminalisation: an update. J Publ Health Policy 1989, Winter: 456–466
  • Rydell CP, Everingham SS. Controlling cocaine. Supply versus demand programs. Drug Policy Research Centre, RAND, Santa Monica, CA 1994
  • Everingham SS, Rydell CP. Modelling the demand for cocaine. RAND Drug Policy Research Center, Santa Monica 1994
  • Edwards G, Anderson P, Babor TF, et al. Alcohol policy and the public good. Oxford University Press, Oxford 1994

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.